Tom Miller
Researcher · Founder
Now Founder, Iambic Therapeutics
Latest on AI4S.fyiFunding · Oct 14 · founderIambic Therapeutics · IPO · $150MAccount links back to iambic.ai · Avatar from their X account, taken 2026-09-28
Affiliations
Current
- Founder · Iambic Therapeutics
Also named in the companies' announcements: Caltech
Current roles come from these dated records, not from the bio below. Each links the page it was read from.
About
Tom Miller is co-founder and chief executive of Iambic Therapeutics, which he has led since 2020. Before that he spent more than ten years as a chemistry professor at Caltech, where he received tenure. He earned a BS in chemistry and mathematics from Texas A&M University and a PhD in theoretical chemistry from the University of Oxford.
Read on 2026-09-29; for current roles see Affiliations above. Read at: hcsandiego.clubs.harvard.edu ↗ · iambic.ai ↗
Selected work
- OrbNet: Deep Learning for Quantum Chemistry Using Symmetry-Adapted Atomic-Orbital Features ↗
A deep learning model that predicts quantum-chemistry properties from atomic-orbital features.
Also on this record: Fred Manby
Each byline was read on the paper itself. Only people on this record are named, not the full author list, and a shared byline does not say who did which part.
Founded
Iambic TherapeuticsDrug discovery · 2019 · 5 rounds on record · disclosed $353M · IPO $150MBackground: Caltech (chemistry professor) (as the company's own announcements put it)
Co-founders: Fred Manby
Backed byMubadala CapitalExor VenturesAscenta CapitalAbingworthCoatueCatalio Capital Management
On the timeline
- 2026-10-14Iambic prices its Nasdaq IPO at $16 a share, the middle of its range, raising $150M before costs
- 2026-10-08Iambic sets its IPO at $15-17 a share, about $150M at the midpoint, and two investors signal interest in up to $60M of it
- 2026-06-22Bayer signs a drug-discovery collaboration with Iambic to use its Enchant and NeuralPLexer models on hard-to-drug targets
Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →